Skip to content
Cromolyn
Gastrocrom (cromolyn) is a small molecule pharmaceutical. Cromolyn was first approved as Intal on 1982-01-01. It is used to treat allergic rhinitis perennial, asthma, bronchial spasm, conjunctivitis, and food hypersensitivity amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
digestive system diseasesD004066
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
eye diseasesD005128
immune system diseasesD007154
Trade Name
FDA
EMA
Gastrocrom (generic drugs available since 1999-06-16, discontinued: Crolom, Cromoptic, Intal, Nasalcrom, Opticrom)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cromolyn sodium
Tradename
Company
Number
Date
Products
GASTROCROMMylanN-020479 RX1996-02-29
1 products, RLD, RS
Show 6 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cromolyn sodiumANDA2023-06-07
gastrocromNew Drug Application2018-10-10
nasalcromANDA2020-08-05
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
allergic rhinitis perennialEFO_1001417D012221J30.89
asthmaEFO_0000270D001249J45
bronchial spasmD001986
conjunctivitisD003231H10
food hypersensitivityEFO_1001890D005512
inflammatory bowel diseasesEFO_0003767D015212
mastocytosisD008415D47.09
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A07: Antidiarrheals, intestinal antiinflammatory/antiinfective agents
A07E: Intestinal antiinflammatory agents
A07EB: Antiallergic intestinal antiinflammatory drugs, excl. corticosteroids
A07EB01: Cromoglicic acid
D: Dermatologicals
D11: Other dermatological preparations in atc
D11A: Other dermatological preparations in atc
D11AH: Agents for dermatitis, excluding corticosteroids
D11AH03: Cromoglicic acid
R: Respiratory system drugs
R01: Nasal preparations
R01A: Decongestants and other nasal preparations for topical use
R01AC: Antiallergic nasal preparations for topical use, excl. corticosteroids
R01AC01: Cromoglicic acid
R01AC51: Cromoglicic acid, combinations
R03: Drugs for obstructive airway diseases
R03B: Other drugs for obstructive airway diseases, inhalants in atc
R03BC: Antiallergic inhalants for obstructive airway diseases, excl. corticosteroids
R03BC01: Cromoglicic acid
S: Sensory organ drugs
S01: Ophthalmologicals
S01G: Decongestants and antiallergics
S01GX: Other antiallergics in atc
S01GX01: Cromoglicic acid
S01GX51: Cromoglicic acid, combinations
HCPCS
Code
Description
J7631
Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
J7632
Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
Clinical
Clinical Trials
424 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0112082239
Septic shockD012772A48.317125426
Adrenal insufficiencyD0003094338320
SepsisD018805A41.9463719
Atopic dermatitisD003876EFO_0000274L20165315
Congenital adrenal hyperplasiaD000312E25.04723115
Post-traumatic stress disordersD013313EFO_0001358F43.113913
Healthy volunteers/patients51129
Addison diseaseD000224E27.1151139
PsoriasisD011565EFO_0000676L4012317
Show 39 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938C9511210224
Prostatic neoplasmsD011471C612115117
LymphomaD008223C85.96612
Myeloid leukemia acuteD015470C92.063210
Myelodysplastic syndromesD009190D46336
Heart arrestD006323EFO_0009492I4622226
Covid-19D000086382U07.1235
PneumoniaD011014EFO_0003106J18314
Bronchopulmonary dysplasiaD001997P27.8224
Atrial fibrillationD001281EFO_0000275I48.011113
Show 35 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 1 diabetes mellitusD003922EFO_0001359E102125
HemorrhoidsD006484EFO_0009552K64314
Down syndromeD004314EFO_0001064Q90213
NeoplasmsD009369C8033
Burkitt lymphomaD002051C83.7133
Opioid-related disordersD009293EFO_0005611F1133
Biphenotypic leukemia acuteD015456C95.022
Head and neck neoplasmsD006258112
Breast neoplasmsD001943EFO_0003869C50112
Large b-cell lymphoma diffuseD016403C83.3122
Show 44 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9426
Polycystic ovary syndromeD011085EFO_0000660E28.222
Hematologic neoplasmsD019337112
Blood pressureD001794EFO_000432522
T-cell lymphomaD01639922
Insulin resistanceD007333EFO_0002614112
Cocaine-related disordersD019970F14112
InfectionsD007239EFO_0000544112
RecurrenceD01200822
T-cell lymphoma peripheralD016411C84.911
Show 23 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperaldosteronismD006929HP_0011736E2633
Major depressive disorderD003865EFO_0003761F2222
Inferior wall myocardial infarctionD056989EFO_100098322
Plantar fasciitisD036981EFO_1001909M72.211
Hip osteoarthritisD015207EFO_1000786M1611
Deglutition disordersD003680HP_0002015R13.111
ThyroidectomyD01396511
Pituitary diseasesD010900E23.711
Circadian rhythm sleep disordersD020178G47.211
HypopituitarismD007018EFO_0001380E23.011
Show 48 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCROMOLYN
INNcromoglicic acid
Description
Cromoglycic acid is a dicarboxylic acid that is the bis-chromone derivative of glycerol. It is effective as a mast cell stabilizer. It has a role as a calcium channel blocker and an anti-asthmatic drug. It is a dicarboxylic acid and a member of chromones. It is a conjugate acid of a cromoglycate(1-).
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1
Identifiers
PDB
CAS-ID16110-51-3
RxCUI42612
ChEMBL IDCHEMBL428880
ChEBI ID59773
PubChem CID2882
DrugBankDB01003
UNII IDY0TK0FS77W (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,513 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
21,226 adverse events reported
View more details